• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[头孢曲松在妇产科领域的基础与临床研究]

[Fundamental and clinical study on ceftriaxone in the field of obstetrics and gynecology].

作者信息

Tsuji Y, Itoh K, Moriyama I, Ichijo M

出版信息

Jpn J Antibiot. 1984 Dec;37(12):2371-6.

PMID:6098731
Abstract

It is reported that ceftriaxone (Ro 13-9904, CTRX) has a half-life time of 7 to 8 hours. In the present study, the serum level 18 hours after intravenous injection with 1 g CTRX was as high as 9.3 micrograms/ml while obviously a higher tissue concentration was maintained compared with other drugs. These facts suggest that CTRX is effective against infections and that the dosage and frequency of administration could be reduced. The global evaluation revealed that CTRX was clinically effective in all the 4 cases with infections. As the adverse reaction, light leukopenia was observed only in 1 case out of the present 4 cases and 20 others administered with CTRX.

摘要

据报道,头孢曲松(Ro 13-9904,CTRX)的半衰期为7至8小时。在本研究中,静脉注射1克CTRX后18小时的血清水平高达9.3微克/毫升,同时与其他药物相比,其组织浓度维持在较高水平。这些事实表明,CTRX对感染有效,且给药剂量和频率可以降低。综合评估显示,CTRX对所有4例感染病例均具有临床疗效。作为不良反应,在本研究的4例病例以及另外20例接受CTRX治疗的病例中,仅1例出现轻度白细胞减少。

相似文献

1
[Fundamental and clinical study on ceftriaxone in the field of obstetrics and gynecology].[头孢曲松在妇产科领域的基础与临床研究]
Jpn J Antibiot. 1984 Dec;37(12):2371-6.
2
[Fundamental and clinical studies on ceftriaxone in the field of obstetrics and gynecology].[头孢曲松在妇产科领域的基础与临床研究]
Jpn J Antibiot. 1984 Dec;37(12):2355-63.
3
[Fundamental and clinical studies of ceftriaxone in the field of obstetrics and gynecology].头孢曲松在妇产科领域的基础与临床研究
Jpn J Antibiot. 1984 Dec;37(12):2364-70.
4
[Fundamental and clinical studies on ceftriaxone in the field of obstetrics and gynecology].[头孢曲松在妇产科领域的基础与临床研究]
Jpn J Antibiot. 1984 Dec;37(12):2328-37.
5
[Fundamental and clinical studies of ceftriaxone in the field of obstetrics and gynecology].头孢曲松在妇产科领域的基础与临床研究
Jpn J Antibiot. 1984 Dec;37(12):2406-15.
6
[Fundamental and clinical study of ceftriaxone in the field of obstetrics and gynecology].头孢曲松在妇产科领域的基础与临床研究
Jpn J Antibiot. 1984 Dec;37(12):2384-90.
7
[Pharmacokinetics and clinical studies on ceftriaxone in the field of obstetrics and gynecology].头孢曲松在妇产科领域的药代动力学及临床研究
Jpn J Antibiot. 1984 Dec;37(12):2304-19.
8
[Basic and clinical studies of ceftriaxone in the field of obstetrics and gynecology].头孢曲松在妇产科领域的基础与临床研究
Jpn J Antibiot. 1984 Dec;37(12):2377-83.
9
[Fundamental and clinical evaluation of ceftriaxone in the field of obstetrics and gynecology].[头孢曲松在妇产科领域的基础与临床评估]
Jpn J Antibiot. 1984 Dec;37(12):2397-405.
10
[Fundamental and clinical evaluation of ceftriaxone in the field of obstetrics and gynecology].头孢曲松在妇产科领域的基础与临床评估
Jpn J Antibiot. 1984 Dec;37(12):2338-42.